NPI: 1033449459 · ANAHEIM, CA 92801 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 01/07/2010
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 01/07/2010 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 24,696 | $1.69M |
| 2019 | 30,517 | $1.61M |
| 2020 | 42,165 | $2.28M |
| 2021 | 44,783 | $2.63M |
| 2022 | 36,734 | $2.17M |
| 2023 | 21,279 | $2.78M |
| 2024 | 6,360 | $1.48M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 78,864 | 6,040 | $11.56M |
| 90945 | 16,186 | 546 | $1.81M | |
| A4657 | Syringe, with or without needle, each | 2,687 | 1,968 | $725K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,852 | 1,017 | $201K |
| J1270 | Injection, doxercalciferol, 1 mcg | 34,156 | 2,904 | $121K |
| 0250 | 2,524 | 470 | $103K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 46,257 | 4,015 | $52K |
| 82728 | 1,156 | 1,020 | $29K | |
| J1756 | Injection, iron sucrose, 1 mg | 12,872 | 3,917 | $29K |
| 90674 | 195 | 180 | $6K | |
| 90662 | 121 | 113 | $2K | |
| 82108 | 118 | 104 | $2K | |
| 85041 | 1,655 | 1,458 | $1K | |
| G0008 | Administration of influenza virus vaccine | 97 | 92 | $1K |
| 90661 | 24 | 24 | $795.84 | |
| 83550 | 1,175 | 1,016 | $710.67 | |
| 83970 | 963 | 841 | $210.97 | |
| 83540 | 1,225 | 1,065 | $79.17 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 256 | 202 | $62.06 |
| 85048 | 1,647 | 1,451 | $8.37 | |
| 85045 | 625 | 568 | $4.83 | |
| 0821 | 95 | 89 | $0.00 | |
| 0301 | 58 | 15 | $0.00 | |
| 0636 | 747 | 59 | $0.00 | |
| 0270 | 28 | 15 | $0.00 | |
| 0305 | 42 | 19 | $0.00 | |
| 0634 | 909 | 78 | $0.00 |